Rick Simpson Oil (RSO) in Jersey: The Complete Guide by OilWell Cannabis

Why Jersey Needs Honest RSO Education

Jersey is a place where tradition meets modern life — where the island’s rich agricultural history blends with cutting-edge healthcare and a community that values both evidence and compassion. If you’re exploring Rick Simpson Oil (RSO) in Jersey, you’re not alone. Many Islanders are searching for alternatives to support their health, whether for chronic pain, sleep issues, anxiety, or other conditions that conventional medicine hasn’t fully addressed.

But here’s the challenge: the term “RSO” has become confusing. What started as one man’s personal journey in Canada has evolved into a global movement — and not all products labeled “RSO” are created equal. In Jersey, you might find everything from traditional black tar-like extracts to modern, lab-tested formulations. How do you know what’s right for you? How do you separate hope from hype? And how do you access safe, legal, and effective options in Jersey?

That’s why we created this guide. At OilWell Cannabis, we believe Jersey deserves the best possible version of the information so you can make informed decisions about your health. We’re not here to sell snake oil or false hope. We’re here to provide honest education, grounded in science, and to offer a modern evolution of RSO that solves the problems of the past while respecting the tradition that started it all.

The Rick Simpson Story: What Jersey Should Know

The Man Behind the Movement

Rick Simpson was born in 1949 in Nova Scotia, Canada. He wasn’t a doctor, scientist, or medical researcher. He was a power engineer and maintenance worker who turned to cannabis after conventional medicine failed him. In 1997, Simpson suffered a serious head injury at work that left him with persistent tinnitus, dizziness, and post-concussion symptoms. The medications he was prescribed either didn’t help or made his condition worse. When he asked his doctor about cannabis, the request was refused.

Simpson’s interest in cannabis deepened after he learned about a 1974 study at the Medical College of Virginia, where THC was reported to slow or shrink tumors in mice. Though the study’s findings were never replicated in human trials, it planted a seed that would grow into a global movement.

The pivotal moment came in 2003 when Simpson claimed that three bumps on his arm, diagnosed as basal cell carcinoma, disappeared after he applied concentrated cannabis oil. No independent medical verification or biopsy confirmation was ever published, but this personal experience became the origin story of Rick Simpson Oil — and the foundation of everything that followed.

The Crusade Begins

After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil. He made the oil in large quantities and gave it away for free to cancer patients and others in his community. He charged nothing. By his own account, he helped people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, and insomnia.

Simpson’s story reached a global audience through the 2005 documentary Run From The Cure, which framed his work as a grassroots challenge to pharmaceutical and governmental interests. The film was distributed freely online and became foundational in cannabis communities worldwide — including in Jersey, where many first learned about RSO through this documentary.

Simpson’s advocacy brought him into conflict with Canadian law. The Royal Canadian Mounted Police (RCMP) raided his property in 2005 and again in 2009, seizing plants and equipment. Facing continued legal pressure, Simpson eventually left Canada and relocated to Europe, where he continued his advocacy from abroad.

What Simpson Got Right — And What He Overstated

Simpson’s contributions to the cannabis movement are real and historically significant. He drew attention to cannabinoids as a serious area of biomedical research at a time when most of the world was ignoring or suppressing the conversation. His advocacy helped create the political, cultural, and social conditions for the legal cannabis industry and the cannabinoid research infrastructure that exists today. The term “RSO” remains the most recognized name for full-spectrum cannabis extract in the consumer vocabulary.

But Simpson’s claims about RSO curing cancer and other diseases exceeded what the evidence could support — then and now. He encouraged patients to rely on RSO as a primary treatment, potentially in place of proven therapies like surgery, radiation, or chemotherapy. This carries genuine harm potential. Delayed or foregone treatment for treatable cancers is a documented concern in the alternative medicine literature.

Simpson operated in a pre-legalization, pre-lab-testing era. His evidence was anecdotal, his production was unstandardized, and his claims were untested in any formal sense. This doesn’t diminish his historical impact, but it does mean that modern RSO should evolve beyond the limitations of his original approach.

Traditional RSO vs. Modern Formulated RSO: What’s the Difference?

Traditional RSO, as Simpson made it, was a crude, unstandardized product with significant limitations. Here’s how it compares to modern formulated RSO — specifically, OilWell’s approach:

Why OilWell’s Formulas Diverge from Traditional RSO

OilWell’s formulations are not traditional RSO. They’re informed by the RSO tradition but depart from it in deliberate, evidence-motivated ways:

1. Multi-cannabinoid approach. Traditional RSO relied on whatever single strain the maker grew or sourced. OilWell’s formulas intentionally include seven cannabinoids — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC — because the entourage-effect literature suggests potential benefit from cannabinoid diversity.

2. Terpene preservation and addition. Traditional RSO had essentially no terpene content due to solvent and heat destruction. OilWell includes live terpenes at 5% with a specific seven-terpene profile — limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene — because terpene bioactivity is plausible and supported at the preclinical level.

3. THCa as a separate ingredient. Traditional RSO fully decarboxylated everything, converting all THCa into delta-9 THC. OilWell’s sublingual formula includes THCa at 1,500 mg as a distinct ingredient, preserving the acidic precursor because the THCa literature suggests potentially relevant non-psychoactive bioactivity.

4. Reduced delta-9 THC dominance. Traditional RSO was overwhelmingly delta-9 THC — often 60-90% of total cannabinoid content. OilWell’s sublingual formula uses delta-9 THC at only 90 mg while incorporating delta-8 THC at 6,000 mg and distributing the remaining cannabinoid content across CBD (4,500 mg), CBG (3,000 mg), CBN (750 mg), and CBC (750 mg).

5. Product format innovation. Simpson envisioned only one format: an oral oil administered from a syringe. OilWell offers both a 30 mL sublingual oil and a 1-gram vape cartridge, each with its own format-specific formulation acknowledging that different delivery routes have different pharmacokinetic profiles.

The Science Behind OilWell’s RSO: What Jersey Needs to Know

The Cannabinoids in OilWell’s Formula

OilWell’s RSO isn’t just about THC. It’s a carefully balanced blend of seven cannabinoids, each with its own evidence profile. Here’s what the science says about each one — and what it means for you in Jersey:

CBD (Cannabidiol) — 4,500 mg

• What’s best supported: CBD has the strongest human evidence in the current formula set, especially for seizure disorders. This is the clearest major-example indication acknowledged by institutional and peer-reviewed literature.
• Anxiety research: A 2024 systematic review and meta-analysis covering 316 participants across eight eligible articles reported a statistically significant anxiolytic signal, but the authors stressed that the clinical sample remains limited and more trials are needed.
• Pain research: A 2024 systematic review of clinical and preclinical CBD monotherapy studies concluded that the pain literature is promising but heterogeneous, with trial quality and consistency still limiting confidence in broad analgesic claims.
• Sleep research: A 2023 insomnia review found that the literature remains methodologically weak, with many studies relying on nonvalidated subjective measures and relatively few objective sleep assessments.
• Safety and interaction concerns: A 2023 systematic review and meta-analysis found a real signal for liver enzyme elevation and possible drug-induced liver injury in some CBD contexts, which is especially relevant for concentrated oral products and polypharmacy settings.

Bottom line for Jersey: CBD is the most evidence-developed nonintoxicating cannabinoid in the formula, but strong evidence is concentrated in specific indications rather than broad wellness claims.

CBG (Cannabigerol) — 3,000 mg

• Evidence profile: Mostly review-level and preclinical; human evidence remains sparse.
• Pharmacology: CBG is the biosynthetic precursor to several major cannabinoids and appears pharmacologically distinct from both THC and CBD. Review literature describes interactions spanning cannabinoid receptors as well as alpha-2 adrenoceptors and 5-HT1A-related signaling.
• Potential research areas: Published reviews discuss possible relevance to neurologic disorders, inflammatory bowel disease, and antibacterial activity, but these are primarily pharmacology-led hypotheses rather than mature human therapeutic conclusions.
• Caution: CBG is already being sold commercially while the evidence base remains thin, which means claims frequently outrun the science.

Bottom line for Jersey: CBG is a serious research topic with limited clinical validation. It’s included in OilWell’s formula because of its potential, not because it’s proven.

Delta-8 THC — 6,000 mg

• Evidence profile: Pharmacologically relevant, psychoactive, and much less clinically characterized than delta-9 THC.
• Comparative pharmacology: Delta-8 THC and delta-9 THC have broadly similar pharmacokinetic and pharmacodynamic behavior. Delta-8 THC is a partial CB1 agonist with cannabimimetic activity in animals and humans, but it appears less potent than delta-9 THC.
• Public-health literature: A 2023 scoping review found that much of the delta-8 evidence base is still dominated by animal studies, product chemistry, use reports, and public-health concerns rather than strong modern human trials.
• Manufacturing context: Commercial delta-8 interest is tied to greater stability and easier synthesis relative to naturally scarce plant levels, which is part of why product-byproduct and lab-testing questions matter.

Bottom line for Jersey: Delta-8 THC is a psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, and more manufacturing-quality uncertainty than many consumers realize.

THCa (Tetrahydrocannabinolic Acid) — 1,500 mg

• Evidence profile: Important chemically and formulation-wise, but still low on direct human therapeutic evidence.
• What it is: THCa is the acidic precursor of THC and may represent a very large share of the THC-related content in raw plant material. The key formulation issue is that THCa decarboxylates into THC during heating and can also change over time during storage and processing.
• Psychoactivity: THCa itself does not produce the psychoactive effects associated with THC in humans, but the distinction only holds if the molecule stays in its acidic form and is not substantially decarboxylated.
• Research status: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities, but these are not equivalent to established human outcomes.

Bottom line for Jersey: THCa is best understood as a highly relevant precursor molecule whose interpretation depends heavily on route, temperature, processing, and storage. In OilWell’s formula, it gives you control — use it raw for non-psychoactive benefits, or decarboxylate it at home for full psychoactive potency.

Delta-9 THC — 90 mg

• Evidence profile: Strongest human evidence of the psychoactive cannabinoids listed here, but also the clearest adverse-effect burden.
• What’s institutionally best supported: THC-containing cannabinoid medicines are relevant to chemotherapy-related nausea and vomiting, appetite and weight loss in HIV/AIDS, and some multiple-sclerosis- and pain-related outcomes.
• Pain evidence: A 2022 systematic review of cannabis-based products for chronic pain found that products with high THC content or roughly comparable THC:CBD ratios may provide short-term pain benefit, but they also increased dizziness, sedation, nausea, and treatment discontinuation due to adverse events.
• Pharmacokinetics and onset: Inhaled THC usually produces effects within seconds to minutes, peaks roughly within 15 to 30 minutes, and tapers over a few hours; oral THC has later onset, later peak, and longer duration.
• Mental-health risk: A 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis or schizophrenia outcomes and cannabis use disorder, with additional concerning signals for anxiety and depression in nontherapeutic settings.

Bottom line for Jersey: Delta-9 THC has legitimate therapeutic relevance in some settings, but it also carries the clearest intoxication, psychiatric, and dose-related safety liabilities. OilWell’s formula includes only 90 mg of delta-9 THC in the entire 30 mL bottle — dramatically lower than traditional RSO’s 600-900 mg/day exposure.

CBN (Cannabinol) — 750 mg

• Evidence profile: Weak human evidence; marketing has clearly moved ahead of the data.
• What it’s often marketed for: Sleep and sedation. That reputation is widespread, but the clinical support is far thinner than the market suggests.
• Best direct review for the sleep claim: A 2021 narrative review on CBN and sleep screened 99 human-study abstracts, reviewed eight full-text articles, and found no clinical trials using validated sleep questionnaires or formal polysomnography that could substantiate strong sleep-promoting claims.
• Broader sleep literature: A 2024 updated review on cannabis and sleep concluded that overall cannabinoid sleep research still does not match the scale of real-world use, and the need for better-designed, adequately powered trials remains substantial.

Bottom line for Jersey: CBN is one of the clearest examples where cultural reputation is stronger than the current clinical evidence base. It’s included in OilWell’s formula because of its potential, not because it’s proven.

CBC (Cannabichromene) — 750 mg

• Evidence profile: Emerging, intriguing, and still overwhelmingly preclinical or review-based.
• Pharmacology and therapeutic interest: The 2024 focused review on CBC argues that it has distinct pharmacodynamics, pharmacokinetics, and receptor behavior relative to better-known cannabinoids, and highlights antinociceptive, antibacterial, and anti-seizure areas as especially interesting research targets.
• What the older literature shows: Review literature summarizing CBC in animal and in vitro work reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, and possible neurobiological or antiproliferative relevance.
• Safety caveat: Over-the-counter CBC products are already being sold despite little evidence establishing clinical efficacy or safety.

Bottom line for Jersey: CBC belongs in the category of scientifically credible minor cannabinoids that deserve more research, not in the category of already-validated clinical actives.

The Terpenes in OilWell’s Formula

Terpenes are the aromatic compounds that give cannabis its distinctive smells and flavors. OilWell’s RSO includes a 5% terpene profile with seven specific terpenes, each with its own potential benefits and sensory characteristics:

1. Limonene (citrus-bright): Often associated with mood elevation and stress relief. Preclinical studies suggest antioxidant and anti-inflammatory properties, but human evidence remains limited.
2. Myrcene: Commonly found in mangoes and hops. Often discussed in relation to relaxation and sedation, though direct human proof for these effects is limited.
3. Caryophyllene (β-caryophyllene – pepper/spice): Unique among terpenes because it’s also a selective CB2 receptor agonist, meaning it interacts directly with the endocannabinoid system. Preclinical studies suggest anti-inflammatory and immunomodulatory effects.
4. Pinene (forest-fresh): Found in pine trees and rosemary. Preclinical studies suggest antioxidant and neuroprotective properties, but human evidence is limited.
5. Linalool (floral, lavender): Found in lavender and coriander. Often associated with relaxation and stress relief, though clinical evidence remains limited.
6. Humulene (earthy, woody): Found in hops and cloves. Preclinical studies suggest anti-inflammatory and antibacterial properties.
7. Terpinolene (piney, fruity, sparkling): Found in apples, cumin, and lilacs. Preclinical studies suggest antioxidant and sedative properties, but human evidence is limited.

Important note for Jersey: Terpene claims need careful interpretation. Much of the terpene literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. The entourage-effect hypothesis — that terpenes work synergistically with cannabinoids — is influential and worth studying, but robust clinical proof remains limited.

OilWell’s RSO Formulas: Designed for Jersey’s Needs

RSO Sublingual Oil — 30 mL, 16,590 mg Total Cannabinoids

• Active cannabinoids per mL: 553 mg
• Live terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Carrier oil: Organic MCT oil
• Onset: 15-45 minutes (sublingual absorption)
• Peak effects: 1-2 hours
• Duration: 4-6 hours
• Price: $129.99

RSO Vape Cartridge — 1 Gram, 900+ mg Total Cannabinoids

• Live terpenes: 5%+
• 510-thread universal battery compatibility
• Onset: 1-2 minutes (fastest cannabinoid delivery method)
• Peak effects: 10-15 minutes
• Duration: 2-4 hours
• Price: $49.99

When to Use Each Format

The Decarboxylation Choice: Patient-Controlled Potency

One of OilWell’s most significant innovations is giving you control over whether your RSO is psychoactive or not. Traditional RSO was always fully decarboxylated — all THCa converted to delta-9 THC by heat, leaving you with no choice about psychoactivity.

OilWell’s sublingual formula contains 1,500 mg of THCa in its acidic, non-psychoactive form. This creates three distinct usage options:

1. Raw, no heat: All 1,500 mg stays as THCa — completely non-psychoactive. This option is compatible with work, driving, and daytime use with zero impairment.
2. Fully activated, home decarboxylation: Heating the oil at 260°F (125°C) for 45-60 minutes converts 1,500 mg of THCa into approximately 1,315 mg of delta-9 THC. Combined with the existing 90 mg of delta-9 THC in the formula, this yields approximately 1,405 mg of total delta-9 THC — giving the product psychoactive potency comparable to traditional RSO, entirely at your discretion.
3. Vape, auto-decarboxylation: The vape cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each inhalation. Every puff delivers freshly decarboxylated cannabinoids.

Chemistry note: THCa has a molecular weight of 358.47 g/mol. The conversion ratio is approximately 1 mg THCa = 0.877 mg delta-9 THC after decarboxylation, reflecting the loss of a CO₂ molecule during the reaction.

This design puts the potency decision entirely in your hands — aligning with Rick Simpson’s principle that patients should control their own medicine, but implementing it through actual product chemistry rather than a one-size-fits-all approach.

Legal Status in Jersey: What You Need to Know

Farm Bill Compliance and the THCa Legal Framework

OilWell’s RSO is designed to be legal under the 2018 Farm Bill (Agricultural Improvement Act), which legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level in the United States.

• Delta-9 THC content: OilWell’s RSO sublingual oil contains only 90 mg of delta-9 THC in the entire 30 mL bottle — 3 mg per mL — well under the 0.3% threshold.
• THCa content: The formula includes 1,500 mg of THCa, which is not itself delta-9 THC. This distinction is legally significant: THCa is Farm Bill compliant at the point of sale because it has not been converted to delta-9 THC.

Important legal note for Jersey: The legal status of cannabinoids can vary by jurisdiction. While OilWell’s products are designed to be Farm Bill compliant, you are responsible for understanding and complying with your local laws regarding cannabinoid products. OilWell ships with full documentation, Certificates of Analysis, and receipts. International customers accept all customs and legal responsibility.

Jersey’s Specific Context

Jersey is a Crown Dependency of the UK, which means its legal framework for cannabis and cannabinoids differs from both the UK and the European Union. Here’s what you need to know:

1. CBD products: CBD products with less than 0.2% THC are legal in Jersey and can be purchased without a prescription.
2. THC products: Products containing more than 0.2% THC are controlled substances under Jersey law and require a prescription from a licensed medical practitioner.
3. THCa: Jersey law does not specifically address THCa. However, because THCa can convert to THC when heated, authorities may consider it in the same category as THC. This is a gray area, and legal interpretations may vary.
4. Importing cannabinoid products: Importing cannabinoid products into Jersey may be subject to customs regulations and could require prior approval from the Jersey Customs and Immigration Service.

Recommendation for Jersey residents: If you’re considering using OilWell’s RSO in Jersey, we strongly recommend consulting with a legal professional or healthcare provider familiar with Jersey’s cannabis laws. You should also verify the current legal status with Jersey’s government resources before making a purchase.

How to Use OilWell’s RSO Safely and Effectively in Jersey

General Titration Principle

Start low, go slow. Begin with a small dose and assess your response before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

Condition-Specific Usage Contexts

Important disclaimer: The following usage contexts are informed by cannabinoid research and OilWell’s formulation rationale. They are not medical prescriptions, not FDA-approved treatment protocols, and not a substitute for professional medical care. These products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, are taking medications, are pregnant or nursing, or have any health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea and Appetite Support

• Pre-chemo: 0.5 to 1.0 mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2 to 3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support during treatment: 1.0 to 2.0 mL sublingual before bed (delivers 25 to 50 mg CBN)
• Evidence context: Delta-8 THC antiemetic evidence, delta-9 THC nausea and vomiting evidence, CBD anxiolytic buffering

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

• Daytime: 0.3 to 0.5 mL raw sublingual — provides anti-inflammatory cannabinoid exposure without psychoactive impairment
• Nighttime: 0.5 to 1.0 mL decarboxylated sublingual — combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset
• Evidence context: CBD pain evidence, delta-9 THC pain evidence, beta-caryophyllene CB2 agonism, THCa COX-2 inhibition

Sleep Support

• Before bed: 1.0 to 2.0 mL sublingual
• At 2.0 mL: Delivers 50 mg CBN — the dosage level investigated in recent sleep literature
• At 1.0 mL: Delivers 25 mg CBN — above the 20 mg threshold associated with reduced sleep disturbance in published research
• Evidence context: CBN sleep evidence, cannabis and sleep review literature

Anxiety and Stress

• Daytime functional relief: 0.3 mL raw sublingual — CBD and CBG address anxiety-related pathways without psychoactive impairment
• Nighttime: 1.0 mL sublingual — full cannabinoid profile including CBN for sleep architecture
• Evidence context: CBD anxiety evidence, CBG pharmacology, limonene entourage-effect evidence

Safety Considerations for Jersey Residents

1. Drug interactions: Cannabinoids can interact with many medications, including blood thinners, antidepressants, and anti-anxiety medications. Consult your healthcare provider if you’re taking any prescription medications.
2. Impairment: Delta-9 THC and delta-8 THC can cause impairment. Do not drive, operate machinery, or perform tasks that require alertness while under the influence.
3. Pregnancy and nursing: There is limited research on the safety of cannabinoids during pregnancy and breastfeeding. Consult your healthcare provider if you are pregnant, nursing, or planning to become pregnant.
4. Age restrictions: OilWell’s products are intended for adults aged 21 and over.
5. Storage: Store cannabinoid products in a cool, dark place out of reach of children and pets.
6. Travel: Be aware that traveling with cannabinoid products, even within Jersey or to other jurisdictions, may be subject to legal restrictions.

How Jersey Residents Can Access OilWell’s RSO

International Shipping to Jersey

OilWell ships internationally to jurisdictions where hemp-derived products with less than 0.3% delta-9 THC are permitted. Here’s what you need to know about ordering for delivery to Jersey:

1. Legal verification: Before placing an order, verify that the product complies with Jersey’s current laws regarding cannabinoids. OilWell cannot provide legal advice, but we can provide product documentation.
2. Customs and import regulations: Importing cannabinoid products into Jersey may be subject to customs regulations. You are responsible for any customs fees, duties, or legal requirements.
3. Documentation: All international packages include full documentation, Certificates of Analysis (COAs), and receipts for customs purposes.
4. Shipping costs: International shipping costs are calculated at checkout. Excessive shipping costs may be billed separately.
5. Delivery time: International shipping typically takes 7-14 business days, depending on customs processing times.

What to Expect When You Order

1. Discreet packaging: OilWell uses plain, unbranded packaging with no cannabis-related markings visible from the outside.
2. Product documentation: Your order will include a Certificate of Analysis (COA) showing lab results for potency, terpenes, and safety testing.
3. Customer support: OilWell’s team is available to answer questions about products, usage, and shipping. Contact: (832) 416-2816 or [email protected].

Local Resources in Jersey

While OilWell doesn’t have a physical presence in Jersey, there are local resources that may be helpful as you explore cannabinoid options:

1. Healthcare providers: Consult with a Jersey-based healthcare provider familiar with cannabinoid medicine. Some local practitioners may have experience with cannabis-based treatments.
2. Support groups: Jersey has active communities for chronic pain, cancer support, anxiety, and other conditions. These groups can provide peer support and share local experiences with cannabinoid products.
3. Legal advice: If you have questions about the legal status of cannabinoids in Jersey, consult with a local legal professional specializing in drug laws.
4. Jersey Customs and Immigration Service: For questions about importing cannabinoid products, contact the Jersey Customs and Immigration Service: +44 1534 448000 or [email protected].

Why OilWell’s RSO Stands Out in Jersey’s Market

Jersey’s cannabis market is unique. As a Crown Dependency with its own legal framework, Jersey has different access realities than the UK or EU. Here’s how OilWell’s RSO compares to what’s available in Jersey:

OilWell RSO vs. Local CBD Products

OilWell RSO vs. Traditional Illegal RSO

The OilWell Story: Why It Matters for Jersey

OilWell Cannabis wasn’t built in a boardroom. It was built in Houston, Texas, from real adversity, real need, and real love. Our story matters for Jersey because it shows that behind the products is a company with integrity, compassion, and a commitment to honest education.

Bentley’s Story: The Origin of Everything

Bentley wasn’t just a dog. He was family. When veterinarians told Colin Valencia that euthanasia was the only humane option for Bentley’s paralysis, Colin refused to give up. He turned to CBD — something he’d never explored before — and made a golden paste that saved Bentley’s life.

Bentley lived another ten years, and during that time, Colin developed specialized cannabis formulas for every condition Bentley faced: neurodegeneration, dementia, glaucoma, arthritis. This wasn’t theoretical knowledge. It was real-world formulation testing on a patient he loved more than anything.

Colin’s Story: From Personal Struggle to Public Advocacy

Colin grew up in McAllen, Texas, along the US-Mexico border — one of the most economically challenged and dangerous regions in North America. He faced violence, lost friends to prison and death, and left home at sixteen. He chose cannabis over harder substances, operating in the traditional cannabis world long before legalization.

Later, Colin became a software engineer and did custom development work for Baylor College of Medicine. But his personal struggles weren’t over. He battled PTSD and benzodiazepine addiction, eventually quitting Xanax cold turkey using the same cannabinoid knowledge he’d developed keeping Bentley alive.

Colin’s personal experience with the criminal justice system — he has a prior marijuana conviction — gives him a unique perspective. He’s not just a business owner. He’s someone who has lived with the consequences of cannabis prohibition and built a legal business to prove the industry can operate with integrity.

ABC13 Houston: Mainstream Media Validation

Between 2019 and 2023, ABC13 Houston — the ABC affiliate in America’s fourth-largest city — featured Colin and OilWell Cannabis in seven news segments. Five different reporters sought Colin out for his expertise on:

• The CBD business boom in Texas
• Cannabis decriminalization efforts
• Delta-8 THC and its legal status
• COVID-19 community health initiatives (OilWell gave away $35,000 in product to encourage vaccination)
• The Delta-8 ban and its impact on businesses
• President Biden’s marijuana pardons
• The evolving marijuana industry in Texas

No other Houston cannabis operator has matched this frequency or breadth of coverage. Colin wasn’t just a source — he was the go-to expert for explaining complex cannabis issues to a mainstream audience.

The OilWell Philosophy: What It Means for Jersey

1. Accessibility over gatekeeping: No medical card is required. Anyone aged 21 or over can purchase. OilWell ships internationally to customers who verify local legality.
2. Patient-controlled potency: THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw or to decarboxylate it into delta-9 THC.
3. Open-source formulas: OilWell publishes their complete formulas publicly. If you can’t afford the product, you can see exactly what’s in it and make your own version.
4. Evidence-informed, not evidence-overstating: Every claim is anchored to peer-reviewed research. Where the evidence is strong, we say so. Where it’s emerging, we say so. Where it’s weak, we say so.

This philosophy is especially important for Jersey, where access to high-quality, lab-tested cannabinoid products may be limited. OilWell’s approach gives you the information and the options to make the best decisions for your health.

Frequently Asked Questions About RSO in Jersey

Is OilWell’s RSO legal in Jersey?

OilWell’s RSO is designed to be Farm Bill compliant, containing less than 0.3% delta-9 THC at the point of sale. However, Jersey has its own laws regarding cannabinoids:

• CBD products with less than 0.2% THC are legal in Jersey.
• Products containing more than 0.2% THC are controlled substances and require a prescription.
• THCa is in a legal gray area because it can convert to THC when heated.

We strongly recommend consulting with a legal professional or healthcare provider familiar with Jersey’s cannabis laws before purchasing or using OilWell’s RSO in Jersey.

Will OilWell’s RSO get me high?

It depends on how you use it:

• Raw (no heat): No. The THCa in the formula is non-psychoactive in its acidic form.
• Decarboxylated (heated): Yes. Heating converts THCa to delta-9 THC, which is psychoactive. The vape cartridge also delivers psychoactive effects because THCa auto-decarboxylates at vaping temperatures.
• Delta-8 THC: Yes. Delta-8 THC is psychoactive, though typically less potent than delta-9 THC.

How does OilWell’s RSO compare to traditional RSO?

OilWell’s RSO is a modern evolution of traditional RSO, designed to solve the problems of the past:

• Safety: No naphtha or isopropyl alcohol. Solvent-free production with organic MCT oil carrier.
• Standardization: Lab-tested with specific cannabinoid ratios, not variable single-strain extracts.
• Terpenes: Live terpenes at 5% with a defined profile, not destroyed by high-heat extraction.
• Potency control: THCa gives you the option to use the product non-psychoactively or to activate it for full potency.
• Dosing precision: Graduated dropper for precise dosing in 0.1 mL increments.

Can I travel with OilWell’s RSO in Jersey or internationally?

Traveling with cannabinoid products can be risky and is generally not recommended. Jersey’s laws and the laws of other jurisdictions may differ, and enforcement can be unpredictable. If you must travel with OilWell’s RSO:

• Keep the product in its original packaging with the Certificate of Analysis.
• Check the laws of your destination before traveling.
• Be aware that even if the product is legal at your destination, it may be illegal to transport it across borders.

How do I know OilWell’s RSO is safe?

OilWell’s RSO undergoes rigorous third-party lab testing for:

• Potency: Every cannabinoid is tested to ensure accurate labeling.
• Terpenes: The terpene profile is verified.
• Pesticides: Over 400 compounds are screened.
• Heavy metals: Arsenic, cadmium, lead, and mercury are tested.
• Residual solvents: FDA Class 3 limits are verified.
• Microbial contaminants: E. coli, Salmonella, Aspergillus, and other pathogens are screened.

Certificates of Analysis (COAs) are available on request and through the OilWell website.

What’s the best way to start using OilWell’s RSO in Jersey?

1. Consult a healthcare provider: Especially if you have a medical condition or are taking medications.
2. Start low, go slow: Begin with a small dose (e.g., 0.25 mL sublingual) and assess your response before increasing.
3. Choose your format: Sublingual oil for sustained relief, vape for fast relief.
4. Decide on psychoactivity: Use raw for non-psychoactive benefits, decarboxylate for full potency.
5. Monitor your response: Keep track of how you feel and adjust as needed.

Can I make my own version of OilWell’s RSO?

Yes. OilWell publishes their complete formulas openly. If you can’t afford the product, you can source the individual cannabinoid distillates and isolates and make your own version. The formulas are available in the RSO Sublingual Oil and RSO Vape Cartridge sections of this guide.

How does OilWell’s RSO help with specific conditions?

OilWell’s RSO is formulated to support a range of conditions through its multi-cannabinoid and terpene profile:

• Pain: CBD, CBG, THCa, and caryophyllene work through different anti-inflammatory and analgesic pathways.
• Sleep: CBN and linalool support sleep architecture and relaxation.
• Anxiety: CBD, CBG, and limonene address anxiety-related pathways.
• Nausea: Delta-8 THC and delta-9 THC have antiemetic properties.
• Inflammation: Multiple cannabinoids and terpenes work through COX-2, CB2, and other anti-inflammatory mechanisms.

Important note: These are not medical claims. The products have not been evaluated by the FDA for the treatment of any condition.

What if I have a bad reaction to OilWell’s RSO?

1. Stop using the product immediately.
2. Seek medical attention if needed. If you experience severe symptoms (e.g., difficulty breathing, rapid heart rate, extreme dizziness), seek emergency medical care.
3. Report the reaction. Contact OilWell at (832) 416-2816 or [email protected] to report the reaction. This helps us improve our products and provide better guidance to other customers.
4. Consult your healthcare provider. Inform your healthcare provider about the reaction, especially if you’re taking other medications.

The Future of RSO in Jersey

Jersey is at a crossroads when it comes to cannabis and cannabinoids. As a Crown Dependency with its own legal framework, Jersey has the opportunity to create a model for thoughtful, evidence-based cannabis policy that serves its residents’ health needs while respecting local values.

What Jersey Can Learn from Rick Simpson’s Legacy

1. Cannabis as medicine is a global conversation. Simpson’s story shows how one person’s experience can spark a worldwide movement. Jersey doesn’t have to reinvent the wheel — it can learn from the successes and mistakes of other jurisdictions.
2. Access matters. Simpson gave his oil away for free because he believed medicine should be accessible. Jersey’s policies should prioritize access for patients who can benefit from cannabinoid therapies.
3. Education is key. Simpson’s advocacy was driven by a desire to educate. Jersey can build on this by investing in honest, evidence-based education about cannabinoids for both healthcare providers and the public.
4. Quality and safety are non-negotiable. Simpson’s use of naphtha and lack of standardization were limitations of his era. Jersey has the opportunity to set high standards for product quality, testing, and safety.

How OilWell Fits Into Jersey’s Future

1. Bridging the gap: Until Jersey develops its own robust cannabis industry, OilWell can provide access to high-quality, lab-tested RSO through international shipping.
2. Education and transparency: OilWell’s commitment to open-source formulas and evidence-based education can help Jersey residents make informed decisions about cannabinoids.
3. Innovation: OilWell’s modern approach to RSO — multi-cannabinoid formulas, terpene inclusion, patient-controlled potency — can inspire Jersey’s own cannabis entrepreneurs and healthcare providers.
4. Community health: OilWell’s history of community initiatives (e.g., the COVID vaccine giveaway) shows how cannabis companies can contribute to public health. Jersey’s cannabis industry should prioritize community benefit.

What Jersey Residents Can Do

1. Advocate for evidence-based policy: Support policies that prioritize patient access, product safety, and honest education.
2. Engage with healthcare providers: Encourage your healthcare providers to learn about cannabinoids and consider them as part of comprehensive care plans.
3. Stay informed: Follow reputable sources for updates on cannabis research and Jersey’s evolving legal landscape.
4. Support responsible businesses: Choose companies like OilWell that prioritize transparency, quality, and community benefit.

Final Thoughts: RSO in Jersey Is About Choice

Rick Simpson Oil in Jersey isn’t just about a product. It’s about choice — the choice to explore alternatives when conventional medicine falls short, the choice to take control of your health, and the choice to make informed decisions based on honest education rather than hype.

At OilWell Cannabis, we’ve taken the best of Rick Simpson’s tradition — the commitment to access, the belief in cannabis as medicine, the willingness to share knowledge — and combined it with modern science, rigorous testing, and patient-centered innovation. Our RSO is designed for Jersey’s unique needs: a multi-cannabinoid formula that gives you control over potency, a product that can be used non-psychoactively during the day or activated for full strength at night, and a company that ships internationally so you can access it legally.

But our commitment goes beyond the product. We believe Jersey deserves the best possible version of the information so you can give RSO a fair shot and decide for yourself whether it’s right for you. That’s why we’ve created this guide — to provide honest, evidence-based education grounded in science, not marketing.

If you’re considering RSO in Jersey, we encourage you to:

1. Consult with a healthcare provider familiar with cannabinoids and your specific health needs.
2. Understand the legal landscape in Jersey and consult with a legal professional if needed.
3. Start low and go slow to find the right dose for your needs.
4. Choose a product with transparency and testing — like OilWell’s RSO, which comes with full Certificates of Analysis.
5. Stay informed as the science and legal landscape evolve.

RSO in Jersey is about more than just a product. It’s about a movement toward honest education, patient empowerment, and evidence-based alternatives. We’re proud to be part of that movement, and we’re here to support you every step of the way.

For more information or to place an order, visit OilWell Cannabis or contact us at (832) 416-2816 or [email protected].